CD34 <sup>+</sup> progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg <sup>null</sup> miceJolien M.R. Van der Meer, Harry Dolstra, Anniek B. van der Waart et al.|OncoImmunology|2021Cited by 19